BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15096562)

  • 21. Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma.
    Wasik AM; Priebe V; Lord M; Jeppsson-Ahlberg Å; Christensson B; Sander B
    Leuk Lymphoma; 2015 May; 56(5):1425-31. PubMed ID: 25120048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative monitoring of cyclin D1 expression: a molecular marker for minimal residual disease monitoring and a predictor of the disease outcome in patients with mantle cell lymphoma.
    Brizova H; Kalinova M; Krskova L; Mrhalova M; Kodet R
    Int J Cancer; 2008 Dec; 123(12):2865-70. PubMed ID: 18798551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorescence PCR quantification of cyclin D1 expression.
    Elenitoba-Johnson KS; Bohling SD; Jenson SD; Lin Z; Monnin KA; Lim MS
    J Mol Diagn; 2002 May; 4(2):90-6. PubMed ID: 11986399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.
    Chuang SS; Huang WT; Hsieh PP; Tseng HH; Campo E; Colomer D; Ye H; Lu CL; Chang HM; Cho CY; Huang SH; Lu YC; Wu JD
    Pathol Int; 2006 Aug; 56(8):440-8. PubMed ID: 16872438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma.
    Krieger S; Gauduchon J; Roussel M; Troussard X; Sola B
    BMC Cancer; 2006 Oct; 6():238. PubMed ID: 17022831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD5-positive, cyclinD1-negative mantle cell lymphoma with a translocation involving the CCND2 gene and the IGL locus.
    Shiller SM; Zieske A; Holmes H; Feldman AL; Law ME; Saad R
    Cancer Genet; 2011 Mar; 204(3):162-4. PubMed ID: 21504716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index.
    Kimura Y; Sato K; Imamura Y; Arakawa F; Kiyasu J; Takeuchi M; Miyoshi H; Yoshida M; Niino D; Sugita Y; Morito T; Yoshino T; Nakamura S; Ohshima K
    Cancer Sci; 2011 Sep; 102(9):1734-41. PubMed ID: 21609366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin D1 expression by histiocytes may mimic cyclin D1-positive proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Wu J; Zhang Y; Sun L; Zhai Q
    Pathol Res Pract; 2018 Jan; 214(1):72-75. PubMed ID: 29254788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
    Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
    Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional and post-transcriptional mechanisms induce cyclin-D1 over-expression in B-chronic lymphoproliferative disorders.
    Sola B; Salaün V; Ballet JJ; Troussard X
    Int J Cancer; 1999 Oct; 83(2):230-4. PubMed ID: 10471532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pathologic diagnosis of mantle cell lymphoma.
    Li S; Xu J; You MJ
    Histol Histopathol; 2021 Oct; 36(10):1037-1051. PubMed ID: 34114641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma.
    Hamborg KH; Bentzen HH; Grubach L; Hokland P; Nyvold CG
    Eur J Haematol; 2012 Nov; 89(5):385-94. PubMed ID: 22827557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D cyclins in CD5+ B-cell lymphoproliferative disorders: cyclin D1 and cyclin D2 identify diagnostic groups and cyclin D1 correlates with ZAP-70 expression in chronic lymphocytic leukemia.
    Meyerson HJ; MacLennan G; Husel W; Cocco A; Tse W; Lazarus HM; Kaplan D
    Am J Clin Pathol; 2006 Feb; 125(2):241-50. PubMed ID: 16393687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of CyclinD1/IgH Detection by FISH in Differential Diagnostic Significance between Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia].
    Li GP; Chen WZ; Huang HF; Chen JD; Lin XL; Fu Q
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1314-7. PubMed ID: 26524029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma.
    Islam TC; Asplund AC; Lindvall JM; Nygren L; Liden J; Kimby E; Christensson B; Smith CI; Sander B
    Leukemia; 2003 Sep; 17(9):1880-90. PubMed ID: 12970790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
    Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
    Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes.
    Korz C; Pscherer A; Benner A; Mertens D; Schaffner C; Leupolt E; Döhner H; Stilgenbauer S; Lichter P
    Blood; 2002 Jun; 99(12):4554-61. PubMed ID: 12036888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of LEF1 in mantle cell lymphoma.
    O'Malley DP; Lee JP; Bellizzi AM
    Ann Diagn Pathol; 2017 Feb; 26():57-59. PubMed ID: 28038713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia.
    Miranda RN; Briggs RC; Kinney MC; Veno PA; Hammer RD; Cousar JB
    Mod Pathol; 2000 Dec; 13(12):1308-14. PubMed ID: 11144927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes.
    Metcalf RA; Zhao S; Anderson MW; Lu ZS; Galperin I; Marinelli RJ; Cherry AM; Lossos IS; Natkunam Y
    Mod Pathol; 2010 Mar; 23(3):420-33. PubMed ID: 20062012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.